Gasco, Florenda M.
HRN: 21-37-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFUROXIME 1.5GM (VIAL)
05/27/2022
05/28/2022
IVT
1.5g
Q8H
S/P TAHBSO; To Continue For 2 More Doses
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes